【摘 要】
：
Introduction: Low hemoglobin density (LHD%) is a new parameter provided by Beckman-Coulter derived from the mean cell hemoglobin concentration, using the mathematical sigmoid transformation LHD% =100
【机 构】
：
Hematology Laboratory, Hospital Galdakao-Usansolo, Galdakao, Spain
【出 处】
：
2013年中国肾性贫血治疗专家共识研讨会
论文部分内容阅读
Introduction: Low hemoglobin density (LHD%) is a new parameter provided by Beckman-Coulter derived from the mean cell hemoglobin concentration, using the mathematical sigmoid transformation LHD% =100 * √1-(1/(1 + e1.8(30-MCHC))).This study investigated the reliability of LHD% for the assessment of iron status in the presence of inflammation.Methods: Healthy subjects (n =90) and patients with iron deficiency (IDA, n =110), chronic kidney disease (CKD, n =65) and anemia of chronic disease (ACD, n =85; 24 were iron deficient and 61 were iron sufficient) were analyzed on a LH 780 analyzer (Beckman Coulter Inc., Miami, FL, USA).Independent samples U test and receiver operating characteristic (ROC) curve analysis were applied.To determine the concordance between LHD% and soluble transferrin receptor (sTrR) Cohens κ index was calculated.Results: LHD % values showed no statistical difference in patients with IDA and patients with ACD accompanied with IDA (P =0.6427); LHD% values in these patients were significantly different (P< 0.0001) compared with the iron-sufficient patients with ACD.ROC analysis for LHD% in the detection of iron deficiency showed the following: area under curve 0.903; cut off 5.5%, sensitivity 88.6%,specificity 76.9%; κ index, 0.65.Conclusion: LHD% is a reliable parameter for the detection of iron deficiency in patients with anemia in the presence of inflammation.
其他文献
Objective-To determine whether recombinant human erythropoietin improves the quality of fife and exercise capacity of anaemic patients receiving haemodialysis.Design-A double blind, randomised, placeb
Haemoglobin (Hgb) levels are known to be associated with numerous adverse outcomes in both chronic kidney disease (CKD) and non-CKD patients.This analysis evaluates the association of baseline haemogl
Anemia associated with chronic renal insufficiency (CRI) may have substantial clinical and public health importance, butlittle is known about its epidemiology.This study aims to quantify the relations
Hemoglobin levels vary substantially over time in hemodialysis patients, and this variability may portend poor.outcomes.For a given patient, hemoglobin concentration over time can be described by abso
Background and objectives: Anemia and hemoglobin (Hb) variability are associated with mortality in hemodialysis patients who are on erythropoiesis-stimulating agents (ESA).Our aim was to describe the
Patients with CKD exhibit significant within-patient hemoglobin (Hb) level variability, especially with the use of erythropoiesis stimulating agents (ESAs) and iron.Analyses of dialysis cohorts in the
National payment policies target a hemoglobin range of 11 to 12.5 g/dl for patients with ESRD.However, clinical complications and provider practices may contribute to wide fluctuations over time.This
Background: Anemia secondary to iron deficiency is common in patients with non-dialysis dependent chronic kidney disease (ND-CKD) but it is unclear if oral supplementation is as effective as intraveno
Background and objectives: Anemia is a common and early complication of nondialysis chronic kidney disease (CKD).One contributing factor is iron deficiency, which may be particularly problematic durin
Background and objectives: Anemia is iron responsive in 30 to 50% of nondialysis patients with chronic kidney disease (CKD), but the utility of bone marrow iron stores and peripheral iron indices to p